OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Bought by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC boosted its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 57.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 169,021 shares of the company’s stock after acquiring an additional 61,412 shares during the period. Mutual of America Capital Management LLC owned about 0.70% of OrthoPediatrics worth $3,918,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp grew its holdings in OrthoPediatrics by 3.8% during the 4th quarter. Bank of New York Mellon Corp now owns 57,710 shares of the company’s stock worth $1,338,000 after acquiring an additional 2,099 shares in the last quarter. AlphaCentric Advisors LLC acquired a new position in OrthoPediatrics during the 4th quarter worth approximately $171,000. Rhumbline Advisers grew its holdings in OrthoPediatrics by 4.1% during the 4th quarter. Rhumbline Advisers now owns 26,411 shares of the company’s stock worth $612,000 after acquiring an additional 1,042 shares in the last quarter. R Squared Ltd acquired a new position in OrthoPediatrics during the 4th quarter worth approximately $48,000. Finally, Harbor Capital Advisors Inc. grew its holdings in OrthoPediatrics by 1.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 251,588 shares of the company’s stock worth $5,832,000 after acquiring an additional 4,728 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on KIDS. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday. Stifel Nicolaus lowered their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Truist Financial lowered their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th.

OrthoPediatrics Trading Up 11.9 %

Shares of OrthoPediatrics stock opened at $25.61 on Thursday. The company has a fifty day simple moving average of $24.39 and a 200-day simple moving average of $25.94. OrthoPediatrics Corp. has a 12-month low of $21.02 and a 12-month high of $35.99. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The stock has a market cap of $620.17 million, a price-to-earnings ratio of -20.82 and a beta of 1.14.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The firm had revenue of $52.67 million during the quarter, compared to the consensus estimate of $51.16 million. During the same quarter in the prior year, the firm earned ($0.23) EPS. On average, equities analysts forecast that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.